IL‐4 inhibits VLA‐4 expression on Tc1 cells resulting in poor tumor infiltration and reduced therapy benefit
Kotaro Sasaki(California Institute for Regenerative Medicine), Walter J. Storkus(University of Pittsburgh)
Cited by 23
Related Papers
STING agonist-based treatment promotes vascular normalization and tertiary lymphoid structure formation in the therapeutic melanoma microenvironment
|Journal for ImmunoTherapy of Cancer|2021|177
Reconstitution of prospermatogonial specification in vitro from human induced pluripotent stem cells
|Nature Communications|2020|147
Reconstitution of human adrenocortical specification and steroidogenesis using induced pluripotent stem cells
|bioRxiv (Cold Spring Harbor Laboratory)|2022|2